Title:
METHODS FOR ELIMINATING HEPATITIS B VIRUS CCCDNA AND RCDNA AND THE HEPATITIS B DRUGS USED IN THE METHODS THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/122555
Kind Code:
A3
Abstract:
Disclosed herein is a method of treating human chronic hepatitis B virus infection by reducing or eliminating cccDNA in liver cell of an HBV infected patient for 3 months or longer.
Inventors:
ZHANG YONG-YUAN (US)
Application Number:
PCT/US2022/081966
Publication Date:
November 02, 2023
Filing Date:
December 21, 2022
Export Citation:
Assignee:
HBVTECH LLC (US)
International Classes:
A61P31/20; A61K39/42; C07K16/08; A61K39/29; C12N15/85
Domestic Patent References:
| WO2019240503A1 | 2019-12-19 |
Foreign References:
| US20210040183A1 | 2021-02-11 | |||
| US20210052566A1 | 2021-02-25 | |||
| US20170152303A1 | 2017-06-01 |
Other References:
LI ET AL.: "A potent human neutralizing antibody Fc-dependently reduces established HBV infections", ELIFE, vol. 6, no. e26738, 26 September 2017 (2017-09-26), pages 1 - 30, XP055727358, DOI: 10.7554/eLife.26738
Attorney, Agent or Firm:
CHEN, Xi (US)
Download PDF: